[go: up one dir, main page]

NO20000284D0 - Tanninsyre-polymerblandinger for kontrollert frigivelse av farmasoeytiske midler, saerlig i munnhulen - Google Patents

Tanninsyre-polymerblandinger for kontrollert frigivelse av farmasoeytiske midler, saerlig i munnhulen

Info

Publication number
NO20000284D0
NO20000284D0 NO20000284A NO20000284A NO20000284D0 NO 20000284 D0 NO20000284 D0 NO 20000284D0 NO 20000284 A NO20000284 A NO 20000284A NO 20000284 A NO20000284 A NO 20000284A NO 20000284 D0 NO20000284 D0 NO 20000284D0
Authority
NO
Norway
Prior art keywords
controlled release
oral cavity
acid polymer
polymer compositions
pharmaceutical agents
Prior art date
Application number
NO20000284A
Other languages
English (en)
Other versions
NO20000284L (no
Inventor
E Itzhak Lerner
Vered Rosenberger
Moshe Flashner
Original Assignee
Perio Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perio Prod Ltd filed Critical Perio Prod Ltd
Publication of NO20000284D0 publication Critical patent/NO20000284D0/no
Publication of NO20000284L publication Critical patent/NO20000284L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20000284A 1997-07-23 2000-01-20 Garvesyre-polymerblandinger for kontrollert frigivelse av farmasøytiske midler, særlig i munnhulen NO20000284L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89912197A 1997-07-23 1997-07-23
PCT/US1998/015096 WO1999004764A1 (en) 1997-07-23 1998-07-22 Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity

Publications (2)

Publication Number Publication Date
NO20000284D0 true NO20000284D0 (no) 2000-01-20
NO20000284L NO20000284L (no) 2000-03-22

Family

ID=25410514

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000284A NO20000284L (no) 1997-07-23 2000-01-20 Garvesyre-polymerblandinger for kontrollert frigivelse av farmasøytiske midler, særlig i munnhulen

Country Status (10)

Country Link
EP (1) EP1003483A1 (no)
JP (1) JP2001510788A (no)
KR (1) KR20010021911A (no)
AU (1) AU8578498A (no)
BR (1) BR9811478A (no)
CA (1) CA2296654A1 (no)
HU (1) HUP0002490A2 (no)
IL (1) IL134151A0 (no)
NO (1) NO20000284L (no)
WO (1) WO1999004764A1 (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7674480B2 (en) 2000-06-23 2010-03-09 Teva Pharmaceutical Industries Ltd. Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
WO2002000213A1 (en) * 2000-06-23 2002-01-03 Teva Pharmaceutical Industries Ltd. Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
US6476006B2 (en) 2000-06-23 2002-11-05 Teva Pharmaceutical Industries, Ltd. Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates
US6881420B2 (en) 2000-06-23 2005-04-19 Teva Pharmaceutical Industries Ltd. Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation
ATE369184T1 (de) * 2000-09-01 2007-08-15 Cognis Ip Man Gmbh Mund- und zahnpflegemittel
JP4820024B2 (ja) * 2001-01-10 2011-11-24 昭和薬品化工株式会社 局所麻酔用組成物
JP5089840B2 (ja) * 2001-09-25 2012-12-05 救急薬品工業株式会社 ニコチン含有フィルム製剤
WO2003039465A2 (en) * 2001-11-05 2003-05-15 Orahealth Corporation Treating canker sores with patches to speed healing and relieve pain
CA2518329C (en) * 2003-03-12 2015-11-24 Epitome Pharmaceuticals Limited Rapidly absorbing lipophilic skin compositions and uses therefor
US20040185009A1 (en) * 2003-03-19 2004-09-23 Dexcel Pharma Technologies Ltd. Composition and device for treating periodontal diseases
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
JP4931596B2 (ja) 2003-11-07 2012-05-16 ユーエス スモークレス タバコ カンパニー リミテッド ライアビリティ カンパニー タバコ組成物
WO2005048965A2 (en) * 2003-11-13 2005-06-02 Wm. Wrigley Jr. Company Method and composition for breath freshening
EP1750683B1 (en) 2004-04-23 2013-01-09 Amgen Inc. Sustained release formulations
WO2007118653A2 (de) * 2006-04-11 2007-10-25 Koko Kosmetikvertrieb Gmbh & Co. Kg Nanopartikel, enthaltend nicotin und/oder cotinin, dispersionen und die verwendung derselben
US8642088B2 (en) 2009-09-04 2014-02-04 Wisconsin Alumni Research Foundation Tannin-chitosan composites
KR101307367B1 (ko) * 2010-09-14 2013-09-25 주식회사 이노테라피 탄닌, 폴리에틸렌글리콜 및 물, 저급 알코올 또는 이들의 혼합물을 포함하는 접착제 조성물
US8865198B2 (en) 2010-10-25 2014-10-21 Dexcel Pharma Technologies Ltd. Method for treating a periodontal disease
FR2972327B1 (fr) * 2011-03-11 2017-08-11 Laboratoires Le Stum Composition nutraceutique mucoadhesive comprenant une association d'antioxydants
GB2496654A (en) * 2011-11-18 2013-05-22 Reckitt & Colman Overseas Self-assembling peptides
US20130158132A1 (en) * 2011-12-19 2013-06-20 Aida Salatinjants Formulation Solution Adapted To Prolong Plasma Times Of Drugs In Mammals Including Humans
WO2015167257A1 (ko) * 2014-04-29 2015-11-05 포항공과대학교 산학협력단 구강 도포용 조성물 및 그 제조 방법
RU2606589C2 (ru) * 2015-02-16 2017-01-10 Александр Александрович Кролевец Способ получения нанокапсул танина
US10532046B2 (en) * 2015-12-03 2020-01-14 Niconovum Usa, Inc. Multi-phase delivery compositions and products incorporating such compositions
CN114364373A (zh) * 2019-08-16 2022-04-15 Amd制药有限公司 粘附性药物递送微粒以及包含该粘附性药物递送微粒的产品
US12234578B2 (en) 2020-01-29 2025-02-25 Wisconsin Alumni Research Foundation Tannin composite fibers
US12303564B2 (en) 2021-03-19 2025-05-20 Wisconsin Alumni Research Foundation Composite chitosan-tannin-active agent compositions and methods of making and using same
CN115477920A (zh) * 2021-06-15 2022-12-16 西南大学 一种单宁酸基水下粘合剂制备方法及制品
KR102836840B1 (ko) 2022-04-13 2025-07-21 경북대학교 산학협력단 치아 수복을 위한 약물 서방성 자가 치유 코팅층 형성용 조성물 및 이의 제조방법
CN117322671A (zh) * 2023-11-01 2024-01-02 东莞市吉纯生物技术有限公司 一种烟碱脂质体及其制备方法与电子雾化液
WO2025183490A1 (ko) * 2024-02-29 2025-09-04 서울대학교 산학협력단 점막 백신 조성물과 그의 사용
CN119488503B (zh) * 2024-11-14 2025-06-27 沈阳盛京生物细胞研发中心有限公司 一种纳米型外泌体胶囊及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB104609A (en) * 1916-06-05 1917-03-15 Monneron & Guye A Method of Manufacturing a Medicinal Aluminium Preparation.
GB918754A (en) * 1959-08-14 1963-02-20 Armour & Co Improvements in or relating to corticotrophin preparations
GB2036750B (en) * 1978-11-23 1983-05-05 Payne M Tannin complexes
JPS5846011A (ja) * 1981-09-14 1983-03-17 Kao Corp 毛髪処理剤
JPH01166763A (ja) * 1987-12-22 1989-06-30 Nitta Gelatin Inc 医科用および歯科用硬化性材料
WO1989010745A1 (en) * 1988-05-02 1989-11-16 Pomerantz, Edwin Compositions and in situ methods for forming films on body tissue
JPH04114655A (ja) * 1990-09-03 1992-04-15 Shinonaga Kasei Kk 医療用硬化組成物
JPH04312522A (ja) * 1991-04-08 1992-11-04 Yoshiaki Kawashima 徐放性錠剤の製造方法
JP3496727B2 (ja) * 1993-12-27 2004-02-16 救急薬品工業株式会社 製剤用基剤
JPH08319232A (ja) * 1995-03-22 1996-12-03 Takeda Chem Ind Ltd 粉粒状組成物
JP2885668B2 (ja) * 1995-09-29 1999-04-26 沢井製薬株式会社 テプレノン製剤

Also Published As

Publication number Publication date
WO1999004764A1 (en) 1999-02-04
CA2296654A1 (en) 1999-02-04
AU8578498A (en) 1999-02-16
KR20010021911A (ko) 2001-03-15
NO20000284L (no) 2000-03-22
HUP0002490A2 (hu) 2000-12-28
JP2001510788A (ja) 2001-08-07
EP1003483A1 (en) 2000-05-31
IL134151A0 (en) 2001-04-30
BR9811478A (pt) 2000-08-15

Similar Documents

Publication Publication Date Title
NO20000284D0 (no) Tanninsyre-polymerblandinger for kontrollert frigivelse av farmasoeytiske midler, saerlig i munnhulen
ATE252562T1 (de) Pyrazolcarbonsäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE69902535D1 (de) Phenoxypropanolamin-derivate, verfahren zu ihrer herstellung und diese enthaltenden pharmazeutischen zusammensetzungen
DE60100186D1 (de) Orale pharmazeutische formulierungen von benzimidazolderivaten und verfahren zu ihrer herstellung
ATE279392T1 (de) Indol-verbindungen, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und ihre medizinische anwendung
HUP0203542A3 (en) 3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
DK1043977T3 (da) Oral farmaceutisk doseringsform baseret på pulserende frigørelse
HUP0202100A3 (en) Novel quinuclidine derivatives, process for their preparation and medicinal compositions containing the same
DZ3191A1 (fr) Composés d'indazole et compositions pharmaceutiques inhibant les protéines kinases, et procédés d'utilisation de ceux-ci.
TR200003788A3 (tr) Yavas salimli oral dozaj bilesim.
HUP0102766A3 (en) Aminomethylcarboxylic acid derivatives, their pharmaceutical use and pharmaceutical compositions comprising them
HUP0103165A3 (en) Thiazoline acid derivatives, pharmaceutical compositions containig the same and their use
IL145012A0 (en) Fluorine substituted triarylmethane derivatives and pharmaceutical compositions containing the same
DE69933307D1 (de) Fliessfähige, wässrige borhaltige zusammensetzungen und verfahren zu ihrer herstellung
DE69934781D1 (de) Morphinsulfat enthaltende mikrogranulate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen
ATE294175T1 (de) 4-sulfonamid-piperidin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
DE60022890D1 (de) Naphthyridine derivate, verfahren zu ihrer herstellung, deren anwendung und sie enthaltende pharmazeutische zusammensetzungen
DE60010113D1 (de) N-guanidinalkylamide, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate
DE60033519D1 (de) Morphinsulfat enthaltende mikrogranulate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen
ATE222586T1 (de) Benzolsulfonamidderivate und verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE60010126D1 (de) Verzweigte substituierte aminoderivate vom 3-amino-1-phenyl-1h[1,2,4]triazol, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
DE60003662D1 (de) Pyridothienodiazepine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
NO975680L (no) Oralt, farmasöytisk preparat av piperidinoalkanol-forbindelser i opplösningsform
DE60200023D1 (de) Isoindoloindolon-Derivate, Verfahren zu ihrer Herstellung und die enthaltende pharmazeutische Zusammensetzungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application